Forum on Regenerative Medicine - Focus Area: Regulatory and Legislative Affairs
As a newly emerging field, regenerative medicine holds much potential for improving health care for patients, but unique regulatory challenges related to product development remain. The Forum has considered a wide variety of challenges including developing regulatory standards, navigating the regulatory approval process, current legislation and policies related to regenerative therapies, and learning from approaches taken to regulating regenerative medicine in other countries. Forum members are interested in understanding the roles of the various regulatory bodies in overseeing therapies and identifying the important steps and considerations involved in the product development process that may help improve the successful translation of therapies. Below are the Forum resources that pertain to regulatory and legislative affairs.
For more information about the Forum on Regenerative Medicine and other focus areas, please visit our homepage.